Skip to Content
You are currently on the new version of our website. Access the old version .
EndocrinesEndocrines
  • Review
  • Open Access

10 June 2022

18 Pages

Estro-Progestins and Pain Relief in Endometriosis

and
1
Obstetrics and Gynecology Department, San Donato Hospital, 52100 Arezzo, Italy
2
Obstetrics and Gynecology, Department of Molecular and Developmental Medicine, University of Siena, Policlinico “Le Scotte” Viale Bracci, 53100 Siena, Italy
*
Author to whom correspondence should be addressed.

Abstract

Endometriosis is a benign, hormone-responsive chronic disease that affects women of reproductive age; long-term treatment to balance satisfactory tolerability with clinical efficacy is necessary for these patients. The first-line therapy for endometriosis is predominantly medical treatment, in order to improve symptoms or prevent post-surgical disease recurrence. Multiple factors including age and women preference, pain severity, and endometriosis stage must be considered in the choice of the most suitable therapy. Estrogen-progestogins are generally used as first-line hormone therapies among different medical options currently effective for endometriosis management. Several studies have shown that they are able to improve pain symptoms in most patients, are well tolerated, and are inexpensive. Combined hormonal contraception treatment, administered cyclically or continuously, with different types of hormones and route of administration, results in clinically noticeable decrease in dysmenorrhea, noncyclic pelvic pain, dyspareunia, and recurrence rate after surgery, and also in quality of life improvement.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.